What Does This Test Measure?
RDW measures the variation in RBC size (anisocytosis). High RDW means RBCs vary widely. It is the earliest CBC sign of iron deficiency (rising before MCV drops) and a key discriminator between iron deficiency and thalassemia trait.
11.5–14.5% (varies by lab).
Why Your Doctor Ordered This Test
RDW is ordered as part of a complete blood count (CBC) whenever a clinician needs to evaluate red blood cell size uniformity. It is a frontline tool in the workup of anemia. In a patient with low hemoglobin, a high RDW indicates that red cells vary markedly in size; this anisocytosis points to a production problem, commonly iron deficiency, where new cells are microcytic while older normocytic cells remain. Physicians order the test to distinguish between iron deficiency anemia (high RDW) and thalassemia trait (normal RDW) when MCV is low. RDW also rises early in mixed nutritional anemias, such as combined iron and B12/folate deficiency, helping to detect brewing deficiencies before MCV shifts. In hospitalized or chronically ill patients, a rising RDW may signal inflammation, malnutrition, or occult blood loss, prompting further investigation. For asymptomatic individuals, an elevated RDW on a routine CBC can trigger a cascade of tests for iron, B12, and underlying chronic disease.
Beyond anemia, RDW has emerged as a powerful prognostic marker. Doctors check RDW in heart failure, coronary artery disease, and critical illness because values above 14.5% are independently linked to increased mortality and adverse cardiovascular events. In these settings, RDW is not used to diagnose a specific cause but rather to stratify risk; it reflects underlying oxidative stress, inflammation, and poor nutritional status. When monitoring response to iron therapy, a falling RDW alongside rising hemoglobin confirms effective treatment. In renal disease, elevated RDW heralds progression and poor outcomes. Clinicians also follow RDW in patients on drugs that cause hemolysis (e.g., dapsone) or in those receiving transfusions, where a sudden spike may indicate acute blood loss with reticulocytosis. Thus, the test aids both diagnostic reasoning and risk assessment.
What High Red Cell Distribution Width Means
High RDW: iron deficiency (earliest CBC sign; RDW rises while MCV is still normal), mixed nutritional deficiencies (iron + B12/folate), recent blood loss or hemolysis with reticulocytosis, post-transfusion, myelodysplasia, and liver disease. High RDW is also an independent predictor of all-cause mortality and cardiovascular events.
What Low Red Cell Distribution Width Means
Low RDW means uniform RBC size, normal. The main clinical value: when MCV is low, a normal RDW strongly suggests thalassemia trait (genetically uniform microcytosis) over iron deficiency (acquired, heterogeneous microcytosis, high RDW).
How to Prepare and What Affects the Result
RDW is measured from a standard whole-blood sample collected in an EDTA (lavender-top) tube; no fasting is required unless drawn as part of a panel that includes fasting glucose or lipids. The sample must be kept at room temperature and analyzed within 24 hours, because prolonged storage leads to red cell swelling and falsely elevated RDW. Hemolyzed or clotted samples can produce erratic RBC histogram widths, so they should be rejected. Strenuous exercise, recent heavy alcohol intake, and acute infection can transiently raise RDW by releasing reticulocytes or causing oxidative damage. Certain drugs directly increase RDW: dapsone, sulfasalazine, and antimalarials provoke hemolysis, while chemotherapy agents cause marked anisocytosis. If a patient has received a blood transfusion within the past few weeks, the donor red cells introduce a distinct population that artificially widens the RDW, so the result does not reflect the patient’s own marrow. Pregnancy lowers the upper reference limit slightly, but values still hover around 14%. When interpreting RDW, always note whether reticulocyte count is elevated, because reticulocytosis from bleeding or treatment (iron, B12) will create a transient high RDW as new cells emerge. No special diet or supplement withholding is needed, but acute iron or vitamin B12 supplementation can change the RDW within days.
Common Misinterpretations
One of the most frequent mistakes is assuming that a normal RDW rules out iron deficiency. In the earliest stage of iron depletion, the bone marrow produces a mix of normocytic and microcytic cells, so RDW rises before hemoglobin or MCV drop. If a clinician dismisses a borderline low MCV with a normal RDW as benign, they may miss incipient thalassemia trait, where microcytosis is genetically uniform and RDW stays normal. Conversely, a high RDW with a normal MCV is often overlooked as nonspecific, yet it can unmask combined iron and B12 deficiency (one pulling MCV down, the other pulling it up), or early iron deficiency without anemia. Another pitfall is using RDW alone to label anemia: isolated high RDW with normal hemoglobin typically indicates reticulocytosis from recent bleeding or hemolysis, not a nutritional cause, and demands a reticulocyte count.
Clinicians sometimes misinterpret a low RDW as a pathological finding, but a low RDW is essentially normal uniform red cells; the real clue is when MCV is low and RDW is normal, strongly suggesting thalassemia trait rather than iron deficiency. Failing to recognize that post-transfusion blood will spike RDW due to two distinct red cell populations leads to unnecessary anemia workups. High RDW in liver disease or myelodysplasia is often misattributed to iron deficiency because both cause macrocytic or dimorphic populations, but the MCV and specific markers (ferritin, B12, folate) clarify the picture. A single elevated RDW in an acutely ill patient is frequently dismissed as "acute phase, " but if it persists beyond the illness, it may unmask smoldering nutrient malabsorption or early bone marrow failure. Finally, ignoring the temporal response: a falling RDW while hemoglobin is still low can indicate good reticulocyte response to iron therapy, so misreading it as persistent disease could lead to unnecessary escalation.
Frequently Asked Questions
What does a high RDW mean on a blood test?
A high RDW indicates red blood cells vary a lot in size (anisocytosis). Common causes include early iron deficiency, where RDW rises before MCV drops, mixed nutritional deficiencies (iron plus B12 or folate), recent blood loss with reticulocytosis, hemolytic anemia, liver disease, and bone marrow disorders such as myelodysplasia. Inflammatory conditions and chronic kidney disease also elevate RDW. It is also an independent predictor of cardiovascular risk. The underlying cause depends on accompanying CBC indices like MCV, hemoglobin, and specific nutrient levels.
What is the difference between RDW and MCV?
Mean corpuscular volume (MCV) measures the average size of red blood cells, indicating whether they are microcytic, normocytic, or macrocytic. RDW measures how much individual red cell sizes deviate from that average, the width of the size distribution. A low MCV with a high RDW points to iron deficiency, while low MCV with a normal RDW suggests thalassemia trait. High MCV with high RDW can indicate mixed B12/folate deficiency, immune hemolysis, or liver disease. Together they classify anemias accurately.
Can a normal RDW rule out iron deficiency?
No. In the earliest stage of iron deficiency, red cell production becomes uneven, some cells shrink while others remain normal, so RDW often rises before hemoglobin or MCV fall. A normal RDW can occur in very mild depletion or if an individual has a genetically uniform red cell population such as thalassemia trait. However, once iron deficiency progresses to anemia, RDW is typically elevated. A low ferritin is the most sensitive early indicator, so a normal RDW should not be used to exclude iron deficiency if suspicion remains.
What cancers cause high RDW?
High RDW is not specific to cancer, but it is frequently elevated in myelodysplastic syndromes (pre-leukemic bone marrow disorders) where the marrow produces misshapen red cells. Colon, stomach, and other gastrointestinal cancers can raise RDW through chronic blood loss and iron deficiency, while hematologic cancers like leukemia and multiple myeloma disrupt normal erythropoiesis. Additionally, cancer-related inflammation, malnutrition, and chemotherapy-induced anisocytosis all contribute. An unexplained high RDW warrants evaluation, but it is not a standalone cancer marker.
What does RDW-CV and RDW-SD mean?
Laboratories report RDW in two ways. RDW-CV (coefficient of variation) is the standard and most commonly used; it expresses the width of the red cell distribution as a percentage of the mean cell size, with normal range 11.5–14.5%. RDW-SD (standard deviation) is the actual width in femtoliters (fL) measured at the 20% frequency level on the histogram. RDW-SD is less influenced by the mean cell size and may be more sensitive in certain macrocytic anemias. Both reflect anisocytosis, but the CV is the index used for routine interpretation.
Related Markers: Read Together for Full Context
BloodWorker reads lab values together, not in isolation. These related markers provide essential context for interpreting your Red Cell Distribution Width result:
Upload Your Bloodwork for Cross-Referenced Analysis
BloodWorker reads all of your markers together , not one at a time , to surface the patterns a thoughtful clinician would notice. Upload your labs and see what the full picture reveals.
Get Started